Drugs Made In America Acquisition (DMAAR) Assets Average (2025)
Drugs Made In America Acquisition (DMAAR) posted Assets Average of $238.8 million for Q4 2025, up 1.0% on a QoQ basis from $236.4 million in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Assets Average (2025) Analysis & Trends
Drugs Made In America Acquisition's Assets Average history runs 1 years deep, the most recent figure standing at $238.8 million for Q4 2025.
- Quarterly Assets Average changed N/A year-over-year to $238.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $238.8 million (changed N/A YoY) and the FY2025 annual result came in at $120.2 million, changed N/A from the prior year.
- Assets Average was $238.8 million for Q4 2025 at Drugs Made In America Acquisition, up from $236.4 million in the prior quarter.
- Across five years, Assets Average topped out at $238.8 million in Q4 2025 and bottomed at $116.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 246.63 Mn |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | 205.96 Mn |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 183.43 Mn |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | 173.09 Mn |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | 2,664.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | 268.80 Mn |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | 373.16 Mn |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 240.31 Mn |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 260.66 Mn |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 238.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 238.78 Mn |
| Sep 30, 2025 | 236.42 Mn |
| Jun 30, 2025 | 234.01 Mn |
| Mar 31, 2025 | 116.68 Mn |